C 16 H 13 FN 2 O 2 , monoclinic, C2/c (no. 15), a = 13.2587(16) Å,
H( A) f . . . . H( A) f . . . . H( B) f . . . . H( A) f − . . . . H( B) f − . . . . H( A) f − . . . . H( B) f − . . . . H( A) f . . . . H( A) f . . . . H( A) f . . . . H( A) f . . . . H( A) f . . . . H( B) f . . . .
Source of material
The title compoiund was synthesized according to a reported procedure [1] . A mixture of 3,5-cyclohexanedione (10 mmol), 4-uorobenzaldehyde (10 mmol), malononitrile (10 mmol) and 4-(dimethylamino)pyridine (DMAP) (1 mmol) in ethanol (100 mL) was re uxed for 2-3 h and then cooled to room temperature. After ltering the precipitates, they were sequentially washed with ice-cooled water and ethanol and then dried under a vacuum. 
Atom Site
x y z U U U U U U C( ) f . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) C( ) f . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) C( ) f . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) C( ) f .( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) .( ) C( ) f . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) . ( ) . ( ) C( ) f . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) . ( ) − . ( ) C( ) f − . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) − . ( ) − . ( ) C( ) f − .( ) . ( ) . ( ) . ( ) . ( ) .( ) − . ( ) . ( ) . ( ) C( ) f − .( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) .( ) C( ) f .( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ). ( ) − . ( ) C( ) f . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) . ( ) . ( ) C( ) f . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) C( ) f . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) C( ) f . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) − . ( ) . ( ) C( ) f . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) . ( ) . ( ) C( ) f . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) . ( ) − . ( ) O( ) f . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) O( ) f − . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) N( ) f . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) − . ( ) N( ) f . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) − . ( ) F( ) f . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) − . ( ) . ( )
Discussion
Dihydropyran derivatives are one of the most commonly encountered heterocycles, which forms the important component of pharmacophores for a number of compounds having medicinal signi cance including anticancer, antiviral, antibacterial, antioxidant, anti-HIV, antihyperglycemic and anti-dyslipidemic activities [2] [3] [4] . Recognizing the considerable importance of the compounds, research focused on the synthesis of dihydropyran derivatives [5] .
In the crystal structure of the title compound, the new formed pyran ring and the adjacent ketone ring are both basically planar, and the two planes are also roughly parallel each other. However, the phenyl ring makes a torsion angle to the pyran ring in the compound.
